Antimicrobial prophylaxis in dermatologic surgery

Cutis

Volumn 79, Issue 6 SUPPL., 2007, Pages 43-51

  Hirschmann, Jan V ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; DERMATOLOGY; HERPES SIMPLEX; HUMAN; INFECTION; METHODOLOGY; MICROBIOLOGY; RISK FACTOR; SURGERY; SURGICAL INFECTION;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; DERMATOLOGY; ENDOCARDITIS, BACTERIAL; HERPES SIMPLEX; HUMANS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION;

EID: 34547513183     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol. 1989;20:367-390.
2. Bansal RC. Infective endocarditis. Med Clin N Am. 1995;79:1205-1240.
3. Carlsson AK, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand. 1977;48:405-410.
4. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
5. Taran LM. Rheumatic fever in its relation to dental disease. N Y J Dent. 1944;14:107-113.
6. Hall G, Hedstrom SA, Heimdahl A, et al. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis. 1993;17:188-194.
7. Lockhart PB. An analysis of bacteremias during dental extractions. a double-blind, placebo-controlled study of Chlorhexidine. Arch Intern Med. 1996;156:513-520.
8. Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis: a review. Medicine. 1977;56: 61-77.
9. Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995;332:38-44.
10. Roberts GJ, Gardner P, Simmons NA. Optimum sampling time for detection of dental bacteraemia in children. Int J Cardiol. 1992;35:311-315.
11. Sabetta JB, Zitelli JA. The incidence of bacteremia during skin surgery. Arch Dermatol. 1987;123:213-215.
12. Halpern AC, Leyden JJ, Dzubow LM, et al. The incidence of bacteremia in skin surgery of the head and neck. J Am Acad Dermatol. 1988;19:112-116.
13. Zack L, Remlinger K, Thompson K, et al. The incidence of bacteremia after skin surgery. J Infect Dis. 1989;159: 148-150.
14. Maurice PDL, Parker S, Azadian BS, et al. Minor skin surgery. are prophylactic antibiotics ever needed for curettage? Acta Derm Venereol. 1991;71:267-268.
15. Carmichael AJ, Flanagan PG, Holt PGA, et al. The occurrence of bacteraemia with skin surgery. Br J Dermatol. 1996;134:120-122.
16. Wilson WR, Van Scoy RE, Washington JA. Incidence of bacteremia in adults without infection. J Clin Microbiol. 1975;2:94-95.
17. Glenchur H, Bhupendrakumar SP, Pathmarajah C. Transient bacteremia associated with debridement of decubitus ulcers. Mil Med. 1981;146:432-433.
18. Richards JH. Bacteremia following irritation of foci of infection. JAMA. 1932;99:1496-1497.
19. Fine BC, Sheckman PR, Bartlett JC. Incision and drainage of soft-tissue abscesses and bacteremia. Ann Intern Med. 1985;103:645.
20. Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses, anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med. 1977;87: 145-149.
21. Brook I, Frazier EH. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg. 1990;125:1445-1451.
22. Bobrow BJ, Pollack CV, Gamble S, et al. Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults. Ann Emerg Med. 1997;29: 404-408.
23. Spelman DW, Weinmann A, Spicer WJ. Endocarditis following skin procedures. J Infect. 1993;26:185-189.
24. Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis: Olmstead County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199-1202.
25. Starkebaum M, Durack D, Beeson P. The "incubation period" of subacute bacterial endocarditis. Yale J Biol Med. 1977;50:49-58.
26. Van der Meer JTM, van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339:135-140.
27. Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. a case control study. Eur Heart J. 1995;16:1968-1974.
28. Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis, a population-based, case-control study. Ann Intern Med. 1998;129: 761-769.
29. Van der Meer JTM, Thompson J, Valkenburg HA, et al. Epidemiology of bacterial endocarditis in the Netherlands, II: antecedent procedures and use of prophylaxis. Arch Intern Med. 1992;152:1869-1873.
30. Lockhart PB, Brennan MT, Kent ML, et al. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures. Circulation. 2004;109: 2878-2884.
31. Baltch AL, Pressman HL, Hammer MC, et al. Bacteremia following dental extractions in patients with and without penicillin prophylaxis. Am J Med Sci. 1982;283: 129-140.
32. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis, analysis of 52 cases submitted to a national registry. JAMA. 1983;250:2318-2322.
33. Horstkotte D, Follath F, Gutschik E, et al, for the Task Force on Infective Endocarditis of the European Society of Cardiology. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary. Eur Heart J. 2004;25:267-276.
34. Wilson W, Taubert K, Gewitz M, et al. Prevention of infective endocarditis, guidelines from the American Heart Association. a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiac Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation [serial online]. April 19, 2007.
35. Ainscow DAP, Denham RA. The risk of haematogenous infection in total joint replacements. J Bone Joint Surg Br. 1984;66:580-582.
36. Deacon JM, Pagliaro AJ, Zelicof SB, et al. Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg Am. 1996;78:1755-1770.
37. Malone JM, Moore WS, Campagna G, et al. Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function. Surgery. 1975;78:211-216.
38. Southwood RT, Rice JL, McDonald PJ, et al. Infection in experimental hip arthroplasties. J Bone Joint Surg Br. 1985;67:229-231.
39. Blomgren G. Hematogenous infection of total joint replacement: an experimental study in the rabbit. Acta Orthop Scand Suppl. 1981;52(suppl 187):1-64.
40. Hirschmann JV. Antimicrobial prophylaxis in dermatology. Sem Cut Med Surg. 2000;19:2-9.
41. Eykyn SJ, Jackson BT, Lockhart-Mummery HE, et al. Prophylactic peroperative intravenous metronidazole in elective colorectal surgery. Lancet. 1979;2(8146):761-764.
42. Feathers RS, Sagor GR, Lewis AA, et al. Prophylactic systemic antibiotics in colorectal surgery. Lancet. 1977;2(8027):4-8.
43. Portnoy J, Kagan E, Gordon PH, et al. Prophylactic antibiotics in elective colorectal surgery. Dis Colon Rectum. 1983;26:310-313.
44. Hill C, Flamant R, Mazas F, et al. Prophylactic cefazolin versus placebo in total hip replacement. report of a multicentre double-blind randomised trial. Lancet. 1981;1(8224):795-796.
45. Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg. 1995;21: 509-514.
46. Whitaker DC, Grande DJ, Johnson SS. Wound infection rate in dermatologic surgery. J Dermatol Surg Oncol. 1988;14:525-528.
47. Griego RD, Zitelli JA. Intra-incisional prophylactic antibiotics for dermatologic surgery. Arch Dermatol. 1998;134:688-692.
48. Huether MJ, Griego RD, Brodland DG, et al. Clindamycin for intraincisional antibiotic prophylaxis in dermatologic surgery. Arch Dermatol. 2002;138:1145-1148.
49. Bencini PL, Galimberti M, Signorini M, et al. Antibiotic prophylaxis of wound infections in skin surgery. Arch Dermatol. 1991;127:1357-1360.
50. Unpublished data. Cited by: Anderson V. Over-the-counter topical antibiotic products: data on safety and efficacy. Int J Dermatol. 1976;15(suppl):l-118.
51. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. a randomized controlled trial. JAMA. 1996;276:972-977.
52. Perkins SW, Sklarew EC. Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast Reconstr Surg. 1996;98:427-433.
53. Wall SH, Ramey SJ, Wall F. Famciclovir as antiviral prophylaxis in laser resurfacing procedures. Plast Reconstr Surg. 1999;104:1103-1108.
54. Beeson WH, Rachel JD. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. Dermatol Surg. 2002;28: 331-336.
55. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg. 1999;25:242-246.